Loading…

Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand

The human leukocyte antigen (HLA) genes are highly variable and are known to play an important role in disease outcomes, including infectious diseases. Prior knowledge of HLA polymorphisms in a population usually forms the basis for an effective case-control study design. As a prelude to future dise...

Full description

Saved in:
Bibliographic Details
Published in:Human immunology 2018-11, Vol.79 (11), p.773-780
Main Authors: Geretz, Aviva, Ehrenberg, Philip K., Bouckenooghe, Alain, Fernández Viña, Marcelo A., Michael, Nelson L., Chansinghakule, Danaya, Limkittikul, Kriengsak, Thomas, Rasmi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13
cites cdi_FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13
container_end_page 780
container_issue 11
container_start_page 773
container_title Human immunology
container_volume 79
creator Geretz, Aviva
Ehrenberg, Philip K.
Bouckenooghe, Alain
Fernández Viña, Marcelo A.
Michael, Nelson L.
Chansinghakule, Danaya
Limkittikul, Kriengsak
Thomas, Rasmi
description The human leukocyte antigen (HLA) genes are highly variable and are known to play an important role in disease outcomes, including infectious diseases. Prior knowledge of HLA polymorphisms in a population usually forms the basis for an effective case-control study design. As a prelude to future disease association analyses, we report HLA class I and II diversity in 334 unrelated donors from a Dengue vaccine efficacy trial conducted in Thailand. Long-range PCR amplification of six HLA loci was performed on DNA extracted from saliva samples. HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1 were genotyped using a next-generation sequencing method presented at the 17th International HLA and Immunogenetics Workshop. In total, we identified 201 HLA alleles, including 35 HLA-A, 57 HLA-B, 28 HLA-C, 24 HLA-DPB1, 21 HLA-DQB1 and 36 HLA-DRB1 alleles. Very common HLA alleles with frequencies greater than 10 percent were A∗11:01:01, A∗33:03:01, A∗24:02:01, B∗46:01:01, C∗07:02:01, C∗01:02:01, C∗08:01:01, DPB1∗05:01:01, DPB1∗13:01:01, DPB1∗04:01:01, DPB1∗02:01:02, DQB1∗03:01:01, DQB1∗05:02:01, DQB1∗03:03:02, DRB1∗12:02:01, DRB1∗09:01:02, and DRB1∗15:02:01. A novel HLA allele, B∗15:450, had a non-synonymous substitution and occurred in more than one donor. Population-based full-length NGS HLA typing is more conclusive and provides a sound foundation for exploring disease association in a given population.
doi_str_mv 10.1016/j.humimm.2018.09.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2111747854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0198885918308607</els_id><sourcerecordid>2111747854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVJaLZp36AUHXOxOyPLlnQphJA0Cwu5pLeC8MrjXS22lUp2SN--WjbNMae5fDP_Px9jXxFKBGy-H8r9MvpxLAWgLsGUAPUHtkKtTIHYNGdsBWh0oXVtLtinlA4AoEDJj-yiAiErbWDFft8tw1AMNO3mPZ_oZS52NFFsZx8mnujPQpPz046Hnt9vrrkb2pT4mrdTx9drfmQT9xNvuQv7EGfexzDyx33rh4x8Zud9OyT68jov2a-728eb-2Lz8HN9c70pnAQ9Fw2JXlG1Nb1S5La1JAVaiEZjpSpZU6tQoNlWSDU6bDppnIOmRtE5J_oOq0t2dbr7FENunGY7-uRoyB0oLMkKRFRS6VpmVJ5QF0NKkXr7FP3Yxr8WwR692oM9ebVHrxaMzV7z2rfXhGU7Uve29F9kBn6cAMp_PnuKNjmf3VHnI7nZdsG_n_APk8yJ8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2111747854</pqid></control><display><type>article</type><title>Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand</title><source>Elsevier</source><creator>Geretz, Aviva ; Ehrenberg, Philip K. ; Bouckenooghe, Alain ; Fernández Viña, Marcelo A. ; Michael, Nelson L. ; Chansinghakule, Danaya ; Limkittikul, Kriengsak ; Thomas, Rasmi</creator><creatorcontrib>Geretz, Aviva ; Ehrenberg, Philip K. ; Bouckenooghe, Alain ; Fernández Viña, Marcelo A. ; Michael, Nelson L. ; Chansinghakule, Danaya ; Limkittikul, Kriengsak ; Thomas, Rasmi</creatorcontrib><description>The human leukocyte antigen (HLA) genes are highly variable and are known to play an important role in disease outcomes, including infectious diseases. Prior knowledge of HLA polymorphisms in a population usually forms the basis for an effective case-control study design. As a prelude to future disease association analyses, we report HLA class I and II diversity in 334 unrelated donors from a Dengue vaccine efficacy trial conducted in Thailand. Long-range PCR amplification of six HLA loci was performed on DNA extracted from saliva samples. HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1 were genotyped using a next-generation sequencing method presented at the 17th International HLA and Immunogenetics Workshop. In total, we identified 201 HLA alleles, including 35 HLA-A, 57 HLA-B, 28 HLA-C, 24 HLA-DPB1, 21 HLA-DQB1 and 36 HLA-DRB1 alleles. Very common HLA alleles with frequencies greater than 10 percent were A∗11:01:01, A∗33:03:01, A∗24:02:01, B∗46:01:01, C∗07:02:01, C∗01:02:01, C∗08:01:01, DPB1∗05:01:01, DPB1∗13:01:01, DPB1∗04:01:01, DPB1∗02:01:02, DQB1∗03:01:01, DQB1∗05:02:01, DQB1∗03:03:02, DRB1∗12:02:01, DRB1∗09:01:02, and DRB1∗15:02:01. A novel HLA allele, B∗15:450, had a non-synonymous substitution and occurred in more than one donor. Population-based full-length NGS HLA typing is more conclusive and provides a sound foundation for exploring disease association in a given population.</description><identifier>ISSN: 0198-8859</identifier><identifier>EISSN: 1879-1166</identifier><identifier>DOI: 10.1016/j.humimm.2018.09.005</identifier><identifier>PMID: 30243890</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alleles ; Computational Biology - methods ; Dengue ; Gene Frequency ; Genes, MHC Class I ; Genes, MHC Class II ; Genotype ; High-Throughput Nucleotide Sequencing ; Histocompatibility Testing ; HLA alleles ; Humans ; Illumina ; Multilocus Sequence Typing ; Next-generation sequencing ; Quantitative Trait Loci ; Thailand</subject><ispartof>Human immunology, 2018-11, Vol.79 (11), p.773-780</ispartof><rights>2018</rights><rights>Copyright © 2018. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13</citedby><cites>FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30243890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Geretz, Aviva</creatorcontrib><creatorcontrib>Ehrenberg, Philip K.</creatorcontrib><creatorcontrib>Bouckenooghe, Alain</creatorcontrib><creatorcontrib>Fernández Viña, Marcelo A.</creatorcontrib><creatorcontrib>Michael, Nelson L.</creatorcontrib><creatorcontrib>Chansinghakule, Danaya</creatorcontrib><creatorcontrib>Limkittikul, Kriengsak</creatorcontrib><creatorcontrib>Thomas, Rasmi</creatorcontrib><title>Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand</title><title>Human immunology</title><addtitle>Hum Immunol</addtitle><description>The human leukocyte antigen (HLA) genes are highly variable and are known to play an important role in disease outcomes, including infectious diseases. Prior knowledge of HLA polymorphisms in a population usually forms the basis for an effective case-control study design. As a prelude to future disease association analyses, we report HLA class I and II diversity in 334 unrelated donors from a Dengue vaccine efficacy trial conducted in Thailand. Long-range PCR amplification of six HLA loci was performed on DNA extracted from saliva samples. HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1 were genotyped using a next-generation sequencing method presented at the 17th International HLA and Immunogenetics Workshop. In total, we identified 201 HLA alleles, including 35 HLA-A, 57 HLA-B, 28 HLA-C, 24 HLA-DPB1, 21 HLA-DQB1 and 36 HLA-DRB1 alleles. Very common HLA alleles with frequencies greater than 10 percent were A∗11:01:01, A∗33:03:01, A∗24:02:01, B∗46:01:01, C∗07:02:01, C∗01:02:01, C∗08:01:01, DPB1∗05:01:01, DPB1∗13:01:01, DPB1∗04:01:01, DPB1∗02:01:02, DQB1∗03:01:01, DQB1∗05:02:01, DQB1∗03:03:02, DRB1∗12:02:01, DRB1∗09:01:02, and DRB1∗15:02:01. A novel HLA allele, B∗15:450, had a non-synonymous substitution and occurred in more than one donor. Population-based full-length NGS HLA typing is more conclusive and provides a sound foundation for exploring disease association in a given population.</description><subject>Alleles</subject><subject>Computational Biology - methods</subject><subject>Dengue</subject><subject>Gene Frequency</subject><subject>Genes, MHC Class I</subject><subject>Genes, MHC Class II</subject><subject>Genotype</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Histocompatibility Testing</subject><subject>HLA alleles</subject><subject>Humans</subject><subject>Illumina</subject><subject>Multilocus Sequence Typing</subject><subject>Next-generation sequencing</subject><subject>Quantitative Trait Loci</subject><subject>Thailand</subject><issn>0198-8859</issn><issn>1879-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMFq3DAQhkVJaLZp36AUHXOxOyPLlnQphJA0Cwu5pLeC8MrjXS22lUp2SN--WjbNMae5fDP_Px9jXxFKBGy-H8r9MvpxLAWgLsGUAPUHtkKtTIHYNGdsBWh0oXVtLtinlA4AoEDJj-yiAiErbWDFft8tw1AMNO3mPZ_oZS52NFFsZx8mnujPQpPz046Hnt9vrrkb2pT4mrdTx9drfmQT9xNvuQv7EGfexzDyx33rh4x8Zud9OyT68jov2a-728eb-2Lz8HN9c70pnAQ9Fw2JXlG1Nb1S5La1JAVaiEZjpSpZU6tQoNlWSDU6bDppnIOmRtE5J_oOq0t2dbr7FENunGY7-uRoyB0oLMkKRFRS6VpmVJ5QF0NKkXr7FP3Yxr8WwR692oM9ebVHrxaMzV7z2rfXhGU7Uve29F9kBn6cAMp_PnuKNjmf3VHnI7nZdsG_n_APk8yJ8w</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Geretz, Aviva</creator><creator>Ehrenberg, Philip K.</creator><creator>Bouckenooghe, Alain</creator><creator>Fernández Viña, Marcelo A.</creator><creator>Michael, Nelson L.</creator><creator>Chansinghakule, Danaya</creator><creator>Limkittikul, Kriengsak</creator><creator>Thomas, Rasmi</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201811</creationdate><title>Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand</title><author>Geretz, Aviva ; Ehrenberg, Philip K. ; Bouckenooghe, Alain ; Fernández Viña, Marcelo A. ; Michael, Nelson L. ; Chansinghakule, Danaya ; Limkittikul, Kriengsak ; Thomas, Rasmi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alleles</topic><topic>Computational Biology - methods</topic><topic>Dengue</topic><topic>Gene Frequency</topic><topic>Genes, MHC Class I</topic><topic>Genes, MHC Class II</topic><topic>Genotype</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Histocompatibility Testing</topic><topic>HLA alleles</topic><topic>Humans</topic><topic>Illumina</topic><topic>Multilocus Sequence Typing</topic><topic>Next-generation sequencing</topic><topic>Quantitative Trait Loci</topic><topic>Thailand</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Geretz, Aviva</creatorcontrib><creatorcontrib>Ehrenberg, Philip K.</creatorcontrib><creatorcontrib>Bouckenooghe, Alain</creatorcontrib><creatorcontrib>Fernández Viña, Marcelo A.</creatorcontrib><creatorcontrib>Michael, Nelson L.</creatorcontrib><creatorcontrib>Chansinghakule, Danaya</creatorcontrib><creatorcontrib>Limkittikul, Kriengsak</creatorcontrib><creatorcontrib>Thomas, Rasmi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Geretz, Aviva</au><au>Ehrenberg, Philip K.</au><au>Bouckenooghe, Alain</au><au>Fernández Viña, Marcelo A.</au><au>Michael, Nelson L.</au><au>Chansinghakule, Danaya</au><au>Limkittikul, Kriengsak</au><au>Thomas, Rasmi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand</atitle><jtitle>Human immunology</jtitle><addtitle>Hum Immunol</addtitle><date>2018-11</date><risdate>2018</risdate><volume>79</volume><issue>11</issue><spage>773</spage><epage>780</epage><pages>773-780</pages><issn>0198-8859</issn><eissn>1879-1166</eissn><abstract>The human leukocyte antigen (HLA) genes are highly variable and are known to play an important role in disease outcomes, including infectious diseases. Prior knowledge of HLA polymorphisms in a population usually forms the basis for an effective case-control study design. As a prelude to future disease association analyses, we report HLA class I and II diversity in 334 unrelated donors from a Dengue vaccine efficacy trial conducted in Thailand. Long-range PCR amplification of six HLA loci was performed on DNA extracted from saliva samples. HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1 were genotyped using a next-generation sequencing method presented at the 17th International HLA and Immunogenetics Workshop. In total, we identified 201 HLA alleles, including 35 HLA-A, 57 HLA-B, 28 HLA-C, 24 HLA-DPB1, 21 HLA-DQB1 and 36 HLA-DRB1 alleles. Very common HLA alleles with frequencies greater than 10 percent were A∗11:01:01, A∗33:03:01, A∗24:02:01, B∗46:01:01, C∗07:02:01, C∗01:02:01, C∗08:01:01, DPB1∗05:01:01, DPB1∗13:01:01, DPB1∗04:01:01, DPB1∗02:01:02, DQB1∗03:01:01, DQB1∗05:02:01, DQB1∗03:03:02, DRB1∗12:02:01, DRB1∗09:01:02, and DRB1∗15:02:01. A novel HLA allele, B∗15:450, had a non-synonymous substitution and occurred in more than one donor. Population-based full-length NGS HLA typing is more conclusive and provides a sound foundation for exploring disease association in a given population.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30243890</pmid><doi>10.1016/j.humimm.2018.09.005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0198-8859
ispartof Human immunology, 2018-11, Vol.79 (11), p.773-780
issn 0198-8859
1879-1166
language eng
recordid cdi_proquest_miscellaneous_2111747854
source Elsevier
subjects Alleles
Computational Biology - methods
Dengue
Gene Frequency
Genes, MHC Class I
Genes, MHC Class II
Genotype
High-Throughput Nucleotide Sequencing
Histocompatibility Testing
HLA alleles
Humans
Illumina
Multilocus Sequence Typing
Next-generation sequencing
Quantitative Trait Loci
Thailand
title Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A57%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Full-length%20next-generation%20sequencing%20of%20HLA%20class%20I%20and%20II%20genes%20in%20a%20cohort%20from%20Thailand&rft.jtitle=Human%20immunology&rft.au=Geretz,%20Aviva&rft.date=2018-11&rft.volume=79&rft.issue=11&rft.spage=773&rft.epage=780&rft.pages=773-780&rft.issn=0198-8859&rft.eissn=1879-1166&rft_id=info:doi/10.1016/j.humimm.2018.09.005&rft_dat=%3Cproquest_cross%3E2111747854%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-6e2f7e3b9f77ecb54e7082268137345ea71219b31e51c16d49cc06512dcc2fd13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2111747854&rft_id=info:pmid/30243890&rfr_iscdi=true